“We are cooperating fully with the government’s investigation.”
Mr. Huber’s biography described him as a partner who “provides extensive research
and analysis on individual companies operating in the health care industry.”
Barry Berke, his lawyer, said in a statement that Mr. Huber denied wrongdoing and
that “his research was based on detailed and rigorous analysis as well as the type of information regularly and properly relied upon by institutional investors in evaluating health care and medical companies.”
A biography for Mr. Olan on Deerfield’s website described him as a “partner on the devices team at Deerfield since 2002.”
David Esseks, Mr. Olan’s lawyer, said, “Rob Olan is an innocent man and looks forward to clearing his name at trial.”
Marc Mukasey, a lawyer for Mr. Fogel, said his client was “resolving this issue and looking forward to the future.”
Mr. Blaszczak used a friend and former colleague, Christopher Worrall, a senior
staff member at the Centers for Medicare and Medicaid Services, as his insider.
Three current and former partners at Deerfield Management, a health care hedge fund firm, paid Mr. Blaszczak to provide inside information about policy decisions at the Centers for Medicare
and Medicaid Services, leading to millions of dollars in illegal profits, federal prosecutors in Manhattan and securities regulators said.
Mr. Blaszczak, a former employee at the agency and founder of Precipio Health Strategies, was accused of pumping a friend at the agency for market-moving information
that he passed to his clients at Deerfield, an unsealed indictment said.